*Primary and Secondary Carnitine Deficiency*: L-Carnitine Injection is used to treat primary and secondary carnitine deficiency, a condition where the body is unable to produce enough carnitine
The compound functions as a non-selective agonist of the melanocortin receptor family, exhibiting activity across multiple receptor subtypes including MC1R, MC3R, MC4R, and MC5R
targetWeightMessageText Vytvo svj et errors } Zpt Odeslali jsme Ti verifikan e-mail
Tozer, R.G., et al., Cysteine-rich protein reverses weight loss in lung cancer patients receiving chemotherapy or radiotherapy
Percentages of proliferative (BrdU + ) (n = 6 technical replicates representative of 2 independent experiments) ( a ) and apoptotic (Annexin V + ) (n = 3 technical replicates representative of 3 independent experiments, **p = 0.0042) ( b ) cells were determined
Just as treatment timelines vary, individual responses to peptide therapy differ based on personal factors